Oncotarget

Research Papers:

N-acetylcysteine negatively regulates Notch3 and its malignant signaling

Xiong Zhang _, Ya-Nan Wang, Juan-Juan Zhu, Xue-Xia Liu, Hui You, Mei-Ying Gong, Ming Zou, Wen-Hsing Cheng and Jian-Hong Zhu

PDF  |  HTML  |  Supplementary Files  |  How to cite

Oncotarget. 2016; 7:30855-30866. https://doi.org/10.18632/oncotarget.8806

Metrics: PDF 2091 views  |   HTML 4696 views  |   ?  


Abstract

Xiong Zhang1,2,*, Ya-Nan Wang1,3,*, Juan-Juan Zhu2, Xue-Xia Liu1, Hui You1, Mei-Ying Gong1, Ming Zou2, Wen-Hsing Cheng5, Jian-Hong Zhu1,2,3,4

1Department of Preventive Medicine, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China

2Department of Geriatrics and Neurology, The Second Affiliated Hospital, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China

3Institute of Nutrition and Diseases, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China

4Key Laboratory of Watershed Science and Health of Zhejiang Province, Wenzhou Medical University, Wenzhou, Zhejiang 325035, China

5Department of Food Science, Nutrition and Health Promotion, Mississippi State University, Mississippi State, Mississippi 39762, USA

*These authors have contributed equally to this work

Correspondence to:

Jian-Hong Zhu, e-mail: [email protected]

Keywords: N-acetylcysteine, Notch3, ROS, lysosome, malignancy

Received: November 12, 2015     Accepted: March 29, 2016     Published: April 18, 2016

ABSTRACT

Notch3 receptor is expressed in a variety of cancers and the excised active intracellular domain (N3ICD) initiates its signaling cascade. N-acetylcysteine (NAC) as an antioxidant has been implicated in cancer prevention and therapy. In this study, we demonstrated a negative regulation of Notch3 by NAC in cancer cells. HeLa cells treated with NAC exhibited a time- and concentration-dependent decrease in Notch3 levels and its downstream effectors Hes1 and HRT1 in a manner independent of f-secretase or glutathione. In contrast, NAC did not affect protein levels of Notch1, the full length Notch3 precursor, or ectopically expressed N3ICD. Although SOD, catalase and NAC suppressed reactive oxygen species in HeLa cells, the first two antioxidants did not impact on Notch3 levels. While the mRNA expression of Notch3 was not altered by NAC, functional inhibition of lysosome, but not proteasome, blocked the NAC-dependent reduction of Notch3 levels. Furthermore, results from Notch3 silencing and N3ICD overexpression demonstrated that NAC prevented malignant phenotypes through down-regulation of Notch3 protein in multiple cancer cells. In summary, NAC reduces Notch3 levels through lysosome-dependent protein degradation, thereby negatively regulates Notch3 malignant signaling in cancer cells. These results implicate a novel NAC treatment in sensitizing Notch3-expressing tumors.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 8806